Determination of solifenacin in human plasma by liquid chromatography-tandem mass spectrometry
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
21071290
DOI
10.1016/j.jchromb.2010.10.010
PII: S1570-0232(10)00644-6
Knihovny.cz E-resources
- MeSH
- Quinuclidines blood chemistry pharmacokinetics MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Linear Models MeSH
- Reproducibility of Results MeSH
- Sensitivity and Specificity MeSH
- Solifenacin Succinate MeSH
- Drug Stability MeSH
- Tandem Mass Spectrometry methods MeSH
- Tetrahydroisoquinolines blood chemistry pharmacokinetics MeSH
- Chromatography, High Pressure Liquid methods MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Quinuclidines MeSH
- Solifenacin Succinate MeSH
- Tetrahydroisoquinolines MeSH
A liquid chromatography-electrospray tandem mass spectrometry method was developed and validated to quantitate solifenacin in human plasma. The assay was based on protein precipitation with methanol and liquid chromatography performed on a pentafluorophenylpropylsilica column (50×4mm, 3μm particles), the mobile phase consisted of methanol - 100mM ammonium acetate containing 1% of formic acid (90:10, v/v). Quantification was through positive-ion mode and selected reaction monitoring at m/z 363→193 and 368→198 for solifenacin and the internal standard solifenacin-D(5), respectively. The lower limit of quantitation was 0.47ng/ml using 0.25ml of plasma and linearity was demonstrated up to 42ng/ml. Intra-assay and inter-assay precision expressed by relative standard deviation was less than 11% and inaccuracy did not exceed 11% at all levels. The assay was applied to the analysis of samples from a pharmacokinetic study.
References provided by Crossref.org